Menu
IBM's new US$1B acquisition will help Watson 'see'

IBM's new US$1B acquisition will help Watson 'see'

The addition of Merge's imaging data could advance personalized medicine, IBM says

IBM expects its acquisition of Merge Healthcare to give Watson the ability to "see."

IBM expects its acquisition of Merge Healthcare to give Watson the ability to "see."

IBM plans to buy Merge Healthcare in a US$1 billion deal that promises to bring new image-focused capabilities to its Watson Health platform.

Under the terms of the acquisition, which was announced Thursday and is expected to close later this year, Merge shareholders will receive $7.13 per share in cash. The deal is IBM's third and largest major health-related acquisition since it launched its Watson Health unit in April.

Merge's technology provides medical image handling and processing and is currently used at more than 7,500 U.S. health care sites. IBM plans to use its Watson Health Cloud to analyze and cross-reference Merge's medical images against lab results, electronic health records, genomic tests, clinical studies and other health-related data sources amounting to 315 billion data points and 90 million unique records.

In effect, IBM believes the combination of the two firms will help advance its Watson cognitive computing system beyond natural language and give it the ability to "see." The goal, it said, is to shed new light on current and historical images, electronic health records and data from wearable devices.

Armed with the new capabilities, clinicians, for example, will be better able to efficiently identify options for the diagnosis, treatment and monitoring of health conditions such as cancer, stroke and heart disease. Researchers, meanwhile, will gain new insights to aid clinical trial design, monitoring and evaluation, IBM said.

Overall, the combination could better equip providers in radiology, cardiology, orthopedics and ophthalmology to deliver more personalized approaches to the diagnosis, treatment and monitoring of patients, it added.

Late last month IBM partnered with CVS Health with a focus on using predictive analytics to help manage chronic diseases. Its other health-related acquisitions this year have included Phytel and Explorys.


Follow Us

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags cloud computingMergers and acquisitionsinternetbusiness issuesIBMindustry verticalshealth careSoftware as a service

Featured

Slideshows

EDGE 2018: Kiwis kick back with Super Rugby before NZ session

EDGE 2018: Kiwis kick back with Super Rugby before NZ session

New Zealanders kick-started EDGE 2018 with a bout of Super Rugby before a dedicated New Zealand session, in front of more than 50 partners, vendors and distributors on Hamilton Island.‚Äč

EDGE 2018: Kiwis kick back with Super Rugby before NZ session
EDGE 2018: Kiwis assess key customer priorities through NZ research

EDGE 2018: Kiwis assess key customer priorities through NZ research

EDGE 2018 kicked off with a dedicated New Zealand track, highlighting the key customer priorities across the local market, in association with Dell EMC. Delivered through EDGE Research - leveraging Kiwi data through Tech Research Asia - more than 50 partners, vendors and distributors combined during an interactive session to assess the changing spending patterns of the end-user and the subsequent impact to the channel.

EDGE 2018: Kiwis assess key customer priorities through NZ research
Show Comments